About The Study: This national analysis of Medicare beneficiaries undergoing cholecystectomy between 2020 and 2023 had 2 principal findings. First, the use of robotic-assisted cholecystectomy continued to increase substantially. Second, despite its growth, robotic-assisted cholecystectomy remained associated with higher risk-adjusted rates of bile duct injury compared with laparoscopic cholecystectomy, while differences in overall complication rates between approaches were small.
Corresponding Author: To contact the corresponding author, Cody Lendon Mullens, MD, MPH, MS, email codymu@med.umich.edu .
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamasurg.2026.1585)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamasurgery/fullarticle/10.1001/jamasurg.2026.1585?guestAccessKey=f785a279-1bbe-445d-8456-0b2dae6e5dc0&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=052726
JAMA Surgery